Table 2.
Perceptions and preventive practices regarding COVID-19 among health care providers in a phone-based survey in five sub-Saharan African countries, 2021*
Burkina Faso | Ethiopia | Nigeria | Tanzania | Ghana | ||
---|---|---|---|---|---|---|
|
Ouagadougou
|
Addis Ababa
|
Ibadan and Lagos
|
Dar es Salaam
|
Kintampo
|
Total
|
Number of health care providers
|
300 |
277 |
312 |
310 |
300 |
1499 |
Concerned about the spread of COVID-19
|
276 (92.0) |
268 (96.7) |
303 (97.1) |
257 (83.0) |
299 (99.7) |
1403(93.6) |
Perceived level of risk of COVID-19 exposure
|
|
|
|
|
|
|
No risk |
4 (1.3) |
1 (0.4) |
2 (0.6) |
12 (3.9) |
4 (1.3) |
23 (1.5) |
Low risk |
122 (40.7) |
36 (13.0) |
29 (9.3) |
29 (9.3) |
28 (9.3) |
244 (16.3) |
High risk |
140 (46.7) |
136 (49.1) |
164 (52.6) |
188 (60.7) |
176(58.7) |
804 (53.6) |
Very high risk |
34 (11.3) |
104 (37.5) |
117 (37.5) |
81 (26.1) |
92 (30.7) |
428 (28.6) |
Preventive measures implemented in the workplace
|
|
|
|
|
|
|
Wearing masks |
295 (98.3) |
275 (99.3) |
311 (99.7) |
279 (90.0) |
298 (99.3) |
1458(97.3) |
Using personal protective equipment |
274 (91.3) |
231(83.4) |
231 (74.0) |
192 (61.9) |
165 (55.0) |
1093 (72.9) |
Hand washing |
296 (98.7) |
258 (93.1) |
309 (99.0) |
299 (96.4) |
300 (100) |
1462 (97.5) |
Keeping sufficient distance between patients |
131 (43.7) |
183 (66.1) |
280 (89.7) |
203 (65.5) |
243 (81.0) |
1040 (69.4) |
Presence of sanitizers/ hand washing station |
268 (89.3) |
208 (75.1) |
301 (96.5) |
303 (97.7) |
293 (97.7) |
1373 (91.6) |
Regular cleaning/decontamination |
268 (89.3) |
220 (79.4) |
286 (91.7) |
241 (77.7) |
292 (97.3) |
1307 (87.2) |
Temperature checks |
257 (85.6) |
154 (55.6) |
279 (89.4) |
208 (67.1) |
288 (96.0) |
1186 (79.1) |
Workplace formulated COVID-19 guidelines/policies |
180 (60.0) |
208 (75.1) |
297 (95.2) |
208 (67.1) |
269 (89.7) |
1162 (77.5) |
COVID-19 formal training/orientation in the workplace in the past 6 months
|
|
|
|
|
|
|
Natural course |
35 (11.7) |
90 (32.5) |
195 (62.5) |
78 (25.2) |
163 (54.3) |
561(37.4) |
Management and treatment |
31 (10.4) |
89 (32.1) |
183 (58.7) |
72 (23.2) |
133 (44.3) |
508 (33.9) |
How vaccines work |
20 (6.7) |
81 (29.2) |
160 (51.3) |
74 (23.9) |
105 (35.0) |
440 (29.3) |
Managing vaccination programs |
36 (12.0) |
77 (27.8) |
112 (35.9) |
66 (21.3) |
52 (17.3) |
343 (22.9) |
Type of COVID-19 treatment available in facility
|
|
|
|
|
|
|
Corticosteroids |
31 (10.3) |
129 (46.6) |
54 (17.3) |
90 (29.0) |
13 (4.3) |
317 (21.1) |
Remdesivir |
3 (1.0) |
73 (26.4) |
31 (9.9) |
11 (3.5) |
0 (0) |
118 (7.9) |
Antibiotics |
131 (43.7) |
174 (62.8) |
136 (43.6) |
176 (56.8) |
91 (30.3) |
708 (47.2) |
Ivermectin |
5 (1.68) |
47 (17.0) |
91 (29.2) |
13 (4.2) |
1 (0.3) |
157 (10.5) |
Chloroquine |
116 (38.7) |
28 (10.1) |
18 (5.8)- |
6 (1.9) |
18 (6.0) |
186 (12.4) |
Multivitamin |
42 (14.0) |
82 (29.6) |
141 (45.2) |
139 (44.5) |
96 (32.0) |
500 (33.4) |
COVID-19 testing available at the workplace
|
175 (58.3) |
240 (86.6) |
205 (65.7) |
111 (35.8) |
112 (37.3) |
843 (56.2) |
If yes, free testing available |
154 (88.0) |
209 (87.1) |
154 (75.1) |
40 (36.0) |
85 (75.9) |
642 (76.2) |
If yes, type of COVID-19 test available† |
|
|
|
|
|
|
PCR |
108 (61.7) |
118 (50.2) |
124 (60.5) |
24 (21.4) |
46 (41.1) |
420 (50.1) |
Antigen |
90 (51.4) |
134 (56.3) |
85 (41.5) |
55 (49.1) |
17 (15.2) |
381 (45.2) |
Ever been tested for COVID-19
|
143 (47.7) |
216 (78.0) |
169 (54.2) |
42 (13.5) |
128 (42.8) |
698 (46.6) |
Tested positive for COVID-19
|
14 (9.8) |
68 (31.5) |
39 (23.1) |
13 (30.9) |
26 (20.3) |
160 (22.9) |
Has treated COVID-19 patients | 101 (33.7) | 232 (83.7) | 146 (47.1) | 144 (46.7) | 82 (27.3) | 705 (47.0) |
N – number of observations
*Number of observations (percentage).
†Counts and percentages do not add up to the total due to multi-response.